Colic Clinical Trial
— CRIOfficial title:
Effect of Prebiotic on Colic and Crying and Fussing Behaviour in Infants CRI Study: Colic Relief Initiative Study
Verified date | August 2019 |
Source | McMaster University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Colic, or inconsolable crying and fussing, affects around 20% of babies who are 3 months of age or younger. To date, there are no known treatments that have been found to help reduce colic and its symptoms in babies. The investigators would like to see whether a baby formula that contains a prebiotic will lead to the same improvements in babies with colic. The investigators will test this by giving some babies a formula with the prebiotic and other babies a placebo formula.
Status | Terminated |
Enrollment | 1 |
Est. completion date | August 15, 2019 |
Est. primary completion date | August 15, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 8 Weeks |
Eligibility |
Inclusion Criteria: - Healthy, term infant from a singleton birth (=>37 weeks gestational age); formula fed; primary caregiver able to read and write in English; current colicky behaviour Exclusion Criteria: - Infants with known genetic syndromes; birth weight (<2500g); use of proton pump inhibitors; use of antibiotics in previous week; use of nutritional colic remedies; use of probiotics; maternal medical history of diabetes (excluding gestational diabetes), tuberculosis, or any perinatal infection while pregnant with child enrolled in study; presence of blood in infant stool sample; possible cow milk protein allergy |
Country | Name | City | State |
---|---|---|---|
Canada | David Braley Health Sciences Centre | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster University | Abbott Nutrition |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Infant crying and fussing behaviour | As assessed by the Barr Baby Behavior Diary | 6 weeks | |
Secondary | Infant crying and fussing behaviour | As assessed by actigraphy and accelerometry | 6 weeks | |
Secondary | Stool Microbiota | 6 weeks | ||
Secondary | Stool calprotectin | 6 weeks | ||
Secondary | Parent satisfaction | As assessed by parent survey | 6 weeks | |
Secondary | Infant behaviour | As assessed by parent survey | 6 weeks | |
Secondary | Infant feeding patterns | As assessed by parent survey | 6 weeks | |
Secondary | Infant stool patterns | As assessed by parent survey | 6 weeks | |
Secondary | Postnatal depression | As assessed by parent survey | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01849991 -
Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic
|
Phase 1 | |
Completed |
NCT01279265 -
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
|
N/A | |
Completed |
NCT00177086 -
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
|
Phase 3 | |
Not yet recruiting |
NCT02577133 -
Prevention of Colic With the Probiotic Lactobacillus Reuteri
|
Phase 2/Phase 3 | |
Recruiting |
NCT01715220 -
Treatment of Suspected Cholelithiasis With Nitroglycerin
|
Phase 2 | |
Completed |
NCT00922727 -
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
|
Phase 1 | |
Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
Completed |
NCT01997593 -
Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected
|
Phase 2 | |
Completed |
NCT01541046 -
Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic
|
Phase 2 | |
Completed |
NCT00929292 -
Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic
|
Phase 3 | |
Terminated |
NCT05554991 -
Human Milk Oligosaccharide (HMO) Supplementation in Colic Management
|
N/A | |
Recruiting |
NCT01067027 -
Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri
|
Phase 4 | |
Recruiting |
NCT04983069 -
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
|
||
Recruiting |
NCT05685030 -
Probiotics Strains for Infant Colic
|
Phase 2 | |
Withdrawn |
NCT05198700 -
The Effect of Probiotics on Symptoms of Infantile Colic
|
Phase 2 | |
Completed |
NCT01532518 -
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
|
Phase 2 | |
Completed |
NCT00796523 -
An Intervention to Decrease Infant Crying
|
N/A | |
Completed |
NCT05052476 -
First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
|
N/A | |
Completed |
NCT02242292 -
Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort
|
Phase 2 | |
Terminated |
NCT00139646 -
Parecoxib in Renal Colic
|
Phase 3 |